Zebra Technologies Co. (NASDAQ:ZBRA) Shares Bought by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. lifted its stake in shares of Zebra Technologies Co. (NASDAQ:ZBRA) by 15.9% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 7,401 shares of the industrial products company’s stock after purchasing an additional 1,014 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in Zebra Technologies were worth $2,878,000 as of its most recent filing with the SEC.

Other large investors have also modified their holdings of the company. Sequoia Financial Advisors LLC bought a new position in Zebra Technologies during the 3rd quarter worth approximately $247,000. Point72 DIFC Ltd bought a new position in Zebra Technologies during the third quarter worth $2,113,000. LVM Capital Management Ltd. MI acquired a new position in Zebra Technologies in the fourth quarter worth $643,000. Versor Investments LP acquired a new position in Zebra Technologies in the third quarter worth $1,752,000. Finally, Cerity Partners LLC increased its stake in Zebra Technologies by 45.3% during the third quarter. Cerity Partners LLC now owns 10,668 shares of the industrial products company’s stock valued at $3,950,000 after purchasing an additional 3,328 shares during the last quarter. Institutional investors own 91.03% of the company’s stock.

Zebra Technologies Stock Performance

ZBRA stock opened at $363.44 on Monday. The company has a market capitalization of $18.75 billion, a P/E ratio of 49.45 and a beta of 1.63. The company has a quick ratio of 0.96, a current ratio of 1.37 and a debt-to-equity ratio of 0.61. The company has a 50-day simple moving average of $397.18 and a 200 day simple moving average of $373.33. Zebra Technologies Co. has a fifty-two week low of $243.49 and a fifty-two week high of $427.76.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on ZBRA shares. Citigroup started coverage on shares of Zebra Technologies in a report on Tuesday, January 14th. They issued a “neutral” rating and a $430.00 price target for the company. Morgan Stanley raised their target price on shares of Zebra Technologies from $400.00 to $427.00 and gave the stock an “equal weight” rating in a report on Tuesday, December 17th. StockNews.com upgraded Zebra Technologies from a “hold” rating to a “buy” rating in a research report on Thursday, October 31st. Robert W. Baird boosted their price objective on Zebra Technologies from $380.00 to $415.00 and gave the company an “outperform” rating in a research report on Wednesday, October 30th. Finally, Truist Financial increased their target price on Zebra Technologies from $408.00 to $409.00 and gave the stock a “hold” rating in a research report on Thursday, January 16th. Five analysts have rated the stock with a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $401.25.

Zebra Technologies Company Profile

Zebra Technologies Corporation, together with its subsidiaries, provides enterprise asset intelligence solutions in the automatic identification and data capture solutions industry worldwide. It operates in two segments, Asset Intelligence & Tracking, and Enterprise Visibility & Mobility. The company designs, manufactures, and sells printers that produce labels, wristbands, tickets, receipts, and plastic cards; dye-sublimination thermal card printers that produce images, which are used for personal identification, access control, and financial transactions; radio frequency identification device (RFID) printers that encode data into passive RFID transponders; accessories and options for printers, including carrying cases, vehicle mounts, and battery chargers; stock and customized thermal labels, receipts, ribbons, plastic cards, and RFID tags for printers; and temperature-monitoring labels primarily used in vaccine distribution.